Sanara MedTech Management
Management criteria checks 1/4
Sanara MedTech's CEO is Seth Yon, appointed in Sep 2025, has a tenure of less than a year. directly owns 1.01% of the company’s shares, worth $2.77M. The average tenure of the management team and the board of directors is 1.1 years and 3.8 years respectively.
Key information
Seth Yon
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 1.0% |
| Management average tenure | 1.1yrs |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
Sanara MedTech Inc. (NASDAQ:SMTI) Doing What It Can To Lift Shares
Aug 13
Tissue Health Plus And OsStic Will Expand Market Reach
Expansion in sales coverage and partnerships aims to boost product adoption, enhancing revenue in both new and existing markets.Sanara MedTech: A Promising Growth Story At An Attractive Valuation
Jan 30Sanara MedTech (NASDAQ:SMTI) Is Carrying A Fair Bit Of Debt
Dec 19US$44.00: That's What Analysts Think Sanara MedTech Inc. (NASDAQ:SMTI) Is Worth After Its Latest Results
Nov 15Sanara MedTech Inc. (NASDAQ:SMTI) Looks Just Right With A 28% Price Jump
Sep 05Here's Why Sanara MedTech (NASDAQ:SMTI) Can Afford Some Debt
Aug 14Sanara MedTech Inc.'s (NASDAQ:SMTI) Shares Not Telling The Full Story
May 23Is Sanara MedTech (NASDAQ:SMTI) Using Too Much Debt?
Nov 15Investors Still Waiting For A Pull Back In Sanara MedTech Inc. (NASDAQ:SMTI)
May 22Sanara MedTech Inc. (NASDAQ:SMTI) Analysts Are Pretty Bullish On The Stock After Recent Results
Mar 22Sanara MedTech: Differentiated Offering With Niche Wound Care Exposure
Sep 06Sanara MedTech reports Q2 results
Aug 15Here's Why We're Not At All Concerned With Sanara MedTech's (NASDAQ:SMTI) Cash Burn Situation
Dec 31Sanara MedTech: Technology For Faster Healing Wounds
Dec 08Companies Like Sanara MedTech (NASDAQ:SMTI) Can Afford To Invest In Growth
May 18The Sanara MedTech (NASDAQ:SMTI) Share Price Has Soared 510%, Delighting Many Shareholders
Feb 19
Is Sanara MedTech Inc. (NASDAQ:SMTI) Popular Amongst Insiders?
Dec 28CEO
Seth Yon
Mr. Seth Yon is Chief Executive Officer and Director of Sanara MedTech Inc. since September 15, 2025 and served as its and Chief Commercial Officer until September 15, 2025. He is President of Sanara MedTe...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Operating Officer | 1.5yrs | US$566.68k | 0.13% $ 355.5k | |
| President | less than a year | no data | 1.01% $ 2.8m | |
| Chief Financial Officer | less than a year | no data | no data | |
| Principal Accounting Officer | less than a year | no data | 0.027% $ 74.5k | |
| Chief Compliance Officer | 5.8yrs | no data | no data | |
| Vice President of Marketing | no data | no data | no data | |
| Chief Corporate Development & Strategy Officer | 1.5yrs | no data | no data | |
| President of Telehealth Services | 5yrs | US$375.69k | no data | |
| Chief R&D Officer | less than a year | no data | no data | |
| Vice President of Corporate Operations | no data | no data | no data | |
| Executive Officer | no data | no data | 0.033% $ 91.8k |
Experienced Management: SMTI's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | no data | 1.01% $ 2.8m | |
| Independent Director | 3.8yrs | US$117.83k | 0.20% $ 545.3k | |
| Independent Director | 3.8yrs | US$112.70k | 0.19% $ 510.6k | |
| Independent Director | 1yr | US$69.13k | 0.055% $ 152.5k | |
| Independent Director | 5yrs | US$122.95k | 0.26% $ 716.5k | |
| Director | 6.2yrs | US$269.91k | 0.26% $ 701.1k | |
| Independent Director | 2.3yrs | US$107.57k | 0.11% $ 289.8k | |
| Independent Director | 4.8yrs | US$107.57k | 0.23% $ 642.3k |
Experienced Board: SMTI's board of directors are considered experienced (3.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/03 04:57 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sanara MedTech Inc. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ross Osborn | Cantor Fitzgerald & Co. |
| Yi Chen | H.C. Wainwright & Co. |